Sepsis AI: Mitigating Risk for Hospital Boardrooms and Investors
Sepsis prediction AI promises to save lives, but a bad rollout can paralyze clinical workflows with alert fatigue…
Generative AI in Clinical Summarization: Investor Due Diligence
Generative AI in clinical documentation is past the hype stage and is now being piloted in major health…
Pediatric AI: The Billion Dollar Unmet Need for Investors
AI is all over healthcare diagnostics, but it’s completely ignoring kids. That’s a huge gap. The reasons are…
AI-Powered Clinical Trials: The Billion-Dollar Investment Opportunity
Clinical trial delays are the bottleneck that bleeds billions from drug developers every year. This isn’t a new…
AI Pathology: De-risking Investment in Digital Diagnostics
Pathology’s shift from glass slides to whole slide imaging is a foundational change that’s finally enabling AI-driven diagnostics.…
Federated Learning: Unlocking Trillion-Dollar Cardiac AI Growth
The biggest thing holding back AI in healthcare has always been data. Getting access to the huge, diverse…
VC Due Diligence: De-Risking Healthcare AI’s Safety & Liability
For venture capital partners, the boom in healthcare AI is a double-edged sword. While the tech promises huge…
Cardiac AI: FFR-CT’s Billion Dollar Market Dominance & Utility
The Shifting Model: From Anatomy to Physiology in CAD Assessment For years, assessing CAD was all about anatomy.…
AI Oncology: De-Risking Investment in Precision Medicine
The idea of artificial intelligence in oncology has been around for ages, starting with clunky, rules-based expert systems…
EHR-Native AI: Investing in the New Deterioration Model Frontier
The field for predictive inpatient clinical decision support is getting turned on its head. What was once the…